Nanobiotix S.A. NBTX
28.56 USD +0.45 (+1.60%)
At closeNov 4, 2026, 4:35 AM EST
29.73 +1.17 +4.09%
Pre-market · Nov 4, 4:35 AM ET
27.91 Day range 29.55
18.58 52-week range 57.14
- YTD
- +23.53%
- 1 year
- +61.36%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 54.38 +90.4% upside
Now 28.56
- Target (low)
- 30.14
- Target (mean)
- 54.38
- Target (high)
- 69.98
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy0
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | -0.54088 | -0.70177 – -0.38 | -0.50 | -8.2% | 29.44M | -9.7% | 2 |
| Next year | -0.1493 | -0.21859 – -0.08 | -0.54088 | +72.4% | 44.36M | +50.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 4, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| May 1, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 2, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Apr 4, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 28, 2024 | Guggenheim | Initiated | — | Buy |
| Dec 8, 2023 | Leerink Partners | Initiated | — | Outperform |
| Jan 6, 2021 | Evercore ISI Group | Initiated | — | Outperform |